Apr 9 |
Kenvue cutting Neutrogena jobs, closing LA office - report
|
Apr 8 |
Kenvue Revamps Cyber Tools After Spinoff From J&J
|
Apr 5 |
Kenvue to Announce First Quarter 2024 Results on May 7, 2024
|
Apr 3 |
Beyond The Numbers: 5 Analysts Discuss Kenvue Stock
|
Mar 12 |
7 High-Quality Blue-Chip Stocks to Buy if You’re Looking for Stability
|
Mar 7 |
Kenvue gains as class action lawsuits over Tylenol/autism link get final dismissals
|
Mar 7 |
Kenvue to Showcase 22 New Sets of Clinical Data at American Academy of Dermatology Association Meeting
|
Mar 5 |
Heard on the Street: Has Bayer Got the Formula to Avoid a Breakup?
|
Feb 22 |
Class action lawsuit vs Kenvue over Tylenol, alleged autism link formally dismissed
|
Feb 13 |
Kenvue to Present at the Consumer Analyst Group of New York Conference on February 23, 2024
|